Cerebrolysin vs NA-Semax Amidate
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: FPE 1070
Cerebrolysin is not a single peptide but a mixture: a preparation of small peptides and free amino acids made by enzymatically breaking down purified porcine (pig) brain protein, manufactured by EVER Neuro Pharma in Austria. It is given by injection and is approved as a prescription drug in dozens of countries for stroke, traumatic brain injury, and dementia, but it is not FDA-approved in the United States. Despite decades of use abroad, the human evidence remains genuinely contested.
Also: N-Acetyl Semax Amidate, NA-Semax
NA-Semax Amidate is the stabilized form of Semax, the Russian nootropic peptide derived from a fragment of ACTH. Same modification logic as the Selank variant: acetyl group at one end, amide at the other, both there to stop enzymes chewing it up before it does anything. It is the most widely used Semax variant in Western nootropic circles, largely on the strength of that stability argument.
Key Comparison Insights
- Both peptides belong to the Cognitive category, suggesting similar primary applications.
Detailed Comparison
| Attribute | Cerebrolysin | NA-Semax Amidate |
|---|---|---|
| Category | Cognitive | Cognitive |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | The proposed idea is that Cerebrolysin's small peptides act like the body's own neurotrophic factors, the molecules such as BDNF and NGF that help neurons survive, grow, and form connections. Researchers hypothesize it engages neurotrophic signaling pathways and may protect neurons from injury and support repair after stroke or brain trauma. It is important to be clear that the exact active components and mechanism are not fully defined, partly because it is a complex biological mixture rather than one purified molecule. So the neurotrophic-mimic story is a plausible hypothesis supported by some lab data, not a precisely mapped pathway. | Semax is a synthetic analog of ACTH (4-10), a fragment of adrenocorticotropic hormone that has been stripped of hormonal activity while retaining effects on the brain. Its best-characterized action is a marked increase in BDNF and NGF expression in the hippocampus, which is the mechanistic basis for the memory and neuroprotection claims. It also modulates dopaminergic and serotonergic transmission, and affects the melanocortin system, which is thought to contribute to its effects on attention and motivation. Notably it does this without the HPA axis activation you would expect from something derived from ACTH, because the fragment lacks the region responsible for that. The acetylation and amidation slow degradation by peptidases, so more of the dose survives to act. |
| Common Dosing | 20-32 mg/day subcutaneous (60mg vial reconstituted in 3 mL bac water = 20 mg/mL) Once or twice daily, split doses above 20 mg into AM/PM, gradual titration | 300-600 mcg daily (intranasal) Once or twice daily, morning and early afternoon |
| Administration | Subcutaneous (research) or intravenous/intramuscular (clinical literature) | Intranasal is the standard and best-supported route, since it was developed as a nasal formulation |
| Typical Duration | 8-16 week protocols for research-scale subQ; 10-20 day cycles for clinical IV | Community protocols commonly report 2-4 week blocks |
| Best Time to Take | Morning | Morning, or morning and early afternoon if split |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Cerebrolysin has been tested in many human trials, but the quality and consistency of that evidence is the real story. A Cochrane systematic review on vascular dementia (Cui and colleagues, 2019) concluded that intravenous Cerebrolysin may improve cognition and global function, but cautioned the findings were not definitive because of high risk of bias and heterogeneity across studies. Cochrane reviews of acute ischemic stroke have similarly found insufficient or inconclusive evidence and have flagged a possible signal of increased non-fatal serious adverse events in some analyses. The Alzheimer's Drug Discovery Foundation's Cognitive Vitality review rates the human evidence as mixed and far from conclusive. So while it is a real, widely prescribed drug in many countries, the claim that it reliably improves brain outcomes is not established to Western regulatory standards, and many of the supporting trials come from a narrow set of investigators and sponsors. | Semax has a genuine and reasonably large research base, concentrated in Russia, where it is a registered medicine used for ischemic stroke, cognitive impairment and optic nerve disorders. Animal work consistently supports the BDNF and NGF upregulation, and there is human clinical work in stroke recovery. The important caveat is the same as for Selank: this literature is largely Russian, much of it predates modern trial standards, replication in large Western randomized trials has not happened, and neither the FDA nor the EMA has assessed it. For the amidate variant specifically there is no independent published pharmacology comparing it to standard Semax in humans. The stability modification is chemically sound and widely used, and the assumption that it improves real-world effect is reasonable but unproven. |
Frequently Asked Questions: Cerebrolysin vs NA-Semax Amidate
What is the difference between Cerebrolysin and NA-Semax Amidate?
Cerebrolysin is a cognitive peptide that cerebrolysin is not a single peptide but a mixture: a preparation of small peptides and free amino acids made by enzymatically breaking down purified porcine (pig) brain protein, manufactured by ever neuro pharma in austria. it is given by injection and is approved as a prescription drug in dozens of countries for stroke, traumatic brain injury, and dementia, but it is not fda-approved in the united states. despite decades of use abroad, the human evidence remains genuinely contested. NA-Semax Amidate is a cognitive peptide that na-semax amidate is the stabilized form of semax, the russian nootropic peptide derived from a fragment of acth. same modification logic as the selank variant: acetyl group at one end, amide at the other, both there to stop enzymes chewing it up before it does anything. it is the most widely used semax variant in western nootropic circles, largely on the strength of that stability argument. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Cerebrolysin or NA-Semax Amidate?
Neither is universally "better" - the choice depends on your specific goals. Cerebrolysin is typically used for cognitive purposes, while NA-Semax Amidate is used for cognitive. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Cerebrolysin and NA-Semax Amidate be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Cerebrolysin and NA-Semax Amidate together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.